With the obesity drug market poised for exponential future growth, here’s the skinny on the top obesity and weight-loss stocks…
Read More »The company also reported record Q4 2023 revenue of $698,591, up 403% over the previous quarter. Elevai Labs Inc. (NASDAQ:…
Read More »ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skin care, is proud to announce the launch of…
Read More »The company’s Q4 top and bottom line figures represent a massive increase of 265% and 765% over last year’s fourth…
Read More »Last Updated: Who were the winners and losers of last week’s big tech earnings season? Let’s take a look at…
Read More »ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, is pleased to announce that the United States…
Read More »With Trump winning decisively again tonight in New Hampshire by double digits, investors should keep an eye on these two…
Read More »ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced certain preliminary, unaudited management-prepared financial results for…
Read More »ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has signed an…
Read More »ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announces participation in three aesthetic industry conferences in…
Read More »









